Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study

被引:23
|
作者
Schmid, Vera [1 ,2 ]
Wagner, Robert [1 ,3 ,4 ]
Sailer, Corinna [1 ,3 ,4 ]
Fritsche, Louise [1 ,3 ,4 ]
Kantartzis, Konstantinos [1 ,3 ,4 ]
Peter, Andreas [1 ,3 ,4 ]
Heni, Martin [1 ,3 ,4 ]
Haering, Hans-Ulrich [1 ,3 ,4 ]
Stefan, Norbert [1 ,3 ,4 ]
Fritsche, Andreas [1 ,3 ,4 ]
机构
[1] Univ Hosp Tubingen, Dept Internal Med 4, Otfried Muller Str 10, D-72076 Tubingen, Germany
[2] Univ Tubingen, Int Res Training Grp 1302, Otfried Muller Str 10, D-72076 Tubingen, Germany
[3] Univ Tubingen, Inst Diabet Res & Metab Dis IDM, Helmholtz Ctr Munich, Tubingen, Germany
[4] German Ctr Diabet Res DZD, Tubingen, Germany
关键词
Fatty liver; Insulin secretion; Insulin sensitivity; Lifestyle intervention; Prediabetes; Predictors; Proinsulin; ACUTE INSULIN-RESPONSE; NORMAL GLUCOSE REGULATION; BETA-CELL FUNCTION; FOLLOW-UP; INDEPENDENTLY PREDICT; FASTING PROINSULIN; WEIGHT-LOSS; TYPE-2; RESISTANCE; TOLERANCE;
D O I
10.1007/s00125-017-4407-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis Lifestyle intervention is effective to prevent type 2 diabetes. However, a considerable long-term non-response occurs to a standard lifestyle intervention. We investigated which risk phenotypes at baseline and their changes during the lifestyle intervention predict long-term glycaemic non-response to the intervention. Methods Of 300 participants at high risk for type 2 diabetes who participated in a 24 month lifestyle intervention with diet modification and increased physical activity, 190 participants could be re-examined after 8.7 +/- 1.6 years. All individuals underwent a five-point 75 g OGTT and measurements of body fat compartments and liver fat content with MRI and spectroscopy at baseline, 9 and 24 months during the lifestyle intervention, and at long-term follow-up. Fasting proinsulin to insulin conversion (PI/I ratio) and insulin sensitivity and secretion were calculated from the OGTT. Non-response to lifestyle intervention was defined as no decrease in glycaemia, i.e. no decrease in AUC for glucose at 0-120 min during OGTT (AUCglucose(0-120) (min)). Results Before the lifestyle intervention, 56% of participants had normal glucose regulation and 44% individuals had impaired fasting glucose and/or impaired glucose tolerance. At long-term follow-up, 11% had developed diabetes. Multivariable regression analysis with adjustment for age, sex, BMI and change in BMI during the lifestyle intervention revealed that baseline insulin secretion and insulin sensitivity, as well as change in insulin sensitivity during the lifestyle intervention, predicted long-term glycaemic control after 9 years. In addition, increased hepatic lipid content as well as impaired fasting proinsulin conversion at baseline were newly detected phenotypes that independently predicted long-term glycaemic control. Conclusions/interpretation Increased hepatic lipid content and impaired proinsulin conversion are new predictors, independent of change in body weight, for non-response to lifestyle intervention in addition to the confirmed factors, impaired insulin secretion and insulin sensitivity.
引用
收藏
页码:2341 / 2351
页数:11
相关论文
共 50 条
  • [31] Long term nutritional intake and the risk for non-alcoholic fatty liver disease a population based study
    Zelber-Sagi, S.
    Nitzan-Kaluski, D.
    Halpern, Z.
    Oren, R.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S291 - S291
  • [32] Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
    Pegah Golabi
    James Paik
    Rashmi Reddy
    Elisabetta Bugianesi
    Gregory Trimble
    Zobair M. Younossi
    BMC Gastroenterology, 19
  • [33] Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
    Golabi, Pegah
    Paik, James
    Reddy, Rashmi
    Bugianesi, Elisabetta
    Trimble, Gregory
    Younossi, Zobair M.
    BMC GASTROENTEROLOGY, 2019, 19 (1)
  • [34] FATTY LIVER DISEASE (FLD), NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD): THE CLINICAL DATA AND LONG-TERM OUTCOMES
    Younossi, Zobair M.
    Paik, James M.
    Afendy, Mariam
    Younossi, Issah
    Golabi, Pegah
    Mishra, Alita
    Henry, Linda
    HEPATOLOGY, 2021, 74 : 1010A - 1010A
  • [35] Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
    Younes, Ramy
    Caviglia, Gian Paolo
    Younes, Ramy
    Caviglia, Gian Paolo
    Govaere, Olivier
    Rosso, Chiara
    Armandi, Angelo
    Sanavia, Tiziana
    Pennisi, Grazia
    Liguori, Antonio
    Francione, Paolo
    Gallego-Duran, Rocio
    Ampuero, Javier
    Blanco, Maria J. Garcia
    Aller, Rocio
    Tiniakos, Dina
    Burt, Alastair
    David, Ezio
    Vecchio, Fabio M.
    Maggioni, Marco
    Cabibi, Daniela
    Pareja, Maria Jesus
    Zaki, Marco Y. W.
    Grieco, Antonio
    Fracanzani, Anna L.
    Valenti, Luca
    Miele, Luca
    Fariselli, Piero
    Petta, Salvatore
    Romero-Gomez, Manuel
    Anstee, Quentin M.
    Bugianesi, Elisabetta
    JOURNAL OF HEPATOLOGY, 2021, 75 (04) : 786 - +
  • [36] Usefulness of Monitoring Serum Cytokeratin-18 levels for Evaluating Long-term Prognosis in Patients with Non-Alcoholic Steatohepatitis/Non-Alcoholic Fatty Liver Disease
    Kawanaka, Miwa
    Nishino, Ken
    Nakamura, Jun
    Oka, Takahito
    Urata, Noriyo
    Goto, Daisuke
    Suehiro, Mitsuhiko
    Kawamoto, Hirofumi
    Yamada, Gotaro
    HEPATOLOGY, 2013, 58 : 474A - 474A
  • [37] Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease
    Viglino, Damien
    Plazanet, Anais
    Bailly, Sebastien
    Benmerad, Meriem
    Jullian-Desayes, Ingrid
    Tamisier, Renaud
    Leroy, Vincent
    Zarski, Jean-Pierre
    Maignan, Maxime
    Joyeux-Faure, Marie
    Pepin, Jean-Louis
    SCIENTIFIC REPORTS, 2018, 8
  • [38] Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease
    Damien Viglino
    Anais Plazanet
    Sebastien Bailly
    Meriem Benmerad
    Ingrid Jullian-Desayes
    Renaud Tamisier
    Vincent Leroy
    Jean-Pierre Zarski
    Maxime Maignan
    Marie Joyeux-Faure
    Jean-Louis Pépin
    Scientific Reports, 8
  • [39] Prevalence and Long-Term Outcomes of Non-Alcoholic Fatty Liver Disease (NAFLD) in Female Subjects in the United States
    Arshad, Tamoore
    Golabi, Pegah
    Paik, James
    Shahab, Omer
    Erario, Madeline
    Younossi, Zobair M.
    HEPATOLOGY, 2018, 68 : 297A - 297A
  • [40] Collagen proportion area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease
    Buzzetti, E.
    Hall, A.
    Ekstedt, M.
    Manuguerra, R.
    Covelli, C.
    Misas, M. G.
    Luong, T. V.
    Kechagias, S.
    Manesis, E. K.
    Pinzani, M.
    Dhillon, A. P.
    Tsochatzis, E.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S52 - S52